Systemic sclerosis & Raynaud's

Quantifying the Need for Specialist Palliative Care Management in Patients With Systemic Sclerosis

Arthritis Care Res (Hoboken)Published Cohort study

Authors' conclusion

SSc is frequently associated with multiple severe symptoms that may be amenable to palliative care intervention.

Study context

Population
Patients with systemic sclerosis (SSc) enrolled in the Australian Scleroderma Cohort Study
Participants
875 patients
Outcome
Need for specialist palliative care: high symptom burden at two or more consecutive study visits, at ≥50% of overall study visits, or at the study visit immediately before death
Methodological detailslogistic regression, linear regression
  • Logistic regression
  • Linear regression

Main finding

As reported in the abstract

Met threshold for specialist palliative care needs

Patients meeting threshold for specialist palliative care needs

72.69%

Observational data: associations, not effects.

Further findings

Prevalence of individual severe symptoms

Severe fatigue (most common)
54.17%
Breathlessness
23.66%
Severe constipation
21.14%
Concurrent severe symptoms frequently observed

Association of severe symptoms with physical quality of life (QoL) (linear regression coefficient)

Severe breathlessness, coef
−7.95, P < 0.01
Severe pain, coef
−7.70, P < 0.01
  • Largest reductions in physical QoL

Association of severe mood symptoms with mental QoL (coefficient)

Severe mood symptoms, coef
−12.91, P < 0.01
  • Greatest reduction in mental QoL

Association of severe symptoms with function (coefficient)

Severe pain, coef
0.56, P < 0.01
Breathlessness, coef
0.49, P < 0.01
Mood symptoms, coef
0.40, P < 0.01

Original publication

Quantifying the Need for Specialist Palliative Care Management in Patients With Systemic Sclerosis. Arthritis Care Res (Hoboken). Published 15 May 2024. doi:10.1002/acr.25325

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.